Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

2.9%

1 terminated/withdrawn out of 35 trials

Success Rate

75.0%

-11.6% vs industry average

Late-Stage Pipeline

17%

6 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

18 recruiting

Enrollment Performance

Analytics

N/A
17(68.0%)
Phase 3
4(16.0%)
Phase 4
2(8.0%)
Phase 2
2(8.0%)
25Total
N/A(17)
Phase 3(4)
Phase 4(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials
NCT06843356Not ApplicableRecruiting

Rescue Endovascular Treatment After Neurological Deterioration in Initially Mild Basilar Artery Occlusion in an Extended Time Window

Role: collaborator

NCT07561814Recruiting

A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data

Role: collaborator

NCT07632677Recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Role: collaborator

NCT05788029Not ApplicableEnrolling By Invitation

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

Role: collaborator

NCT06597227Not ApplicableRecruiting

Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy

Role: collaborator

NCT06462313Not ApplicableCompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Role: collaborator

NCT06085690Not ApplicableRecruiting

Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT07147335Recruiting

The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients

Role: lead

NCT07132008Phase 3Not Yet Recruiting

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Role: collaborator

NCT07093294Recruiting

Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study

Role: collaborator

NCT07067840Not ApplicableNot Yet Recruiting

Triple Branched Stent Graft System for Aortic Arch Lesions

Role: collaborator

NCT07046676Phase 4Recruiting

Pharmacogenetics-Based Study on Individualized Use of Sodium Valproate

Role: lead

NCT06979037Recruiting

Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research

Role: lead

NCT06941649Not ApplicableNot Yet Recruiting

Efficacy of Two Approaches in Cervical Single-door Laminoplasty for Spinal Canal Enlargement

Role: collaborator

NCT06790108Not ApplicableRecruiting

Validation of an AI-Assisted Mediastinal EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Trial

Role: collaborator

NCT02966483Not ApplicableRecruiting

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Role: collaborator

NCT05598528Recruiting

Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)

Role: collaborator

NCT05574517Not ApplicableRecruiting

Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter

Role: lead

NCT06529562Not ApplicableRecruiting

Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.

Role: collaborator